Clover Health Investments, Corp. announced that on January 6, 2023, the Board of Directors of the company appointed Jamie L. Reynoso as Chief Executive Officer of Medicare Advantage, effective immediately. Ms. Reynoso had previously served as Chief Operating Officer of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.89 USD | -4.48% | +8.54% | -6.52% |
05-07 | Transcript : Clover Health Investments, Corp., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | Earnings Flash (CLOV) CLOVER HEALTH INVESTMENTS Posts Q1 Revenue $346.9M, vs. Street Est of $321.2M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.52% | 441M | |
-0.35% | 483B | |
+16.15% | 127B | |
+13.11% | 96.22B | |
-22.19% | 42.92B | |
+5.19% | 41.66B | |
-3.79% | 20.37B | |
-15.68% | 1.39B |
- Stock Market
- Equities
- CLOV Stock
- News Clover Health Investments, Corp.
- Clover Health Investments, Corp. Appoints Jamie L. Reynoso as Chief Executive Officer of Medicare Advantage